$21.63 -$0.32 (-1.5%)

04:00 PM EST on 11/22/19

Iovance Biotherapeutics Inc (NASDAQ:IOVA)

CAPS Rating: 1 out of 5

Current Price $21.63 Mkt Cap $2.8B
Open $22.03 P/E Ratio 0.00
Prev. Close $21.95 Div. (Yield) $0.00 (0.0%)
Daily Range $20.79 - $22.10 Volume 992,844
52-Wk Range $8.26 - $26.59 Avg. Daily Vol. 1,229,580

Caps

How do you think NASDAQ:IOVA will perform against the market?

Add Stock to CAPS Watchlist

All Players

26 Outperform
32 Underperform
 

All-Star Players

6 Outperform
23 Underperform
 

Wall Street

1 Outperform
1 Underperform
 

Top NASDAQ:IOVA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

zzlangerhans (99.78)
Submitted June 08, 2016

#zzporte has owned Lion since 2014 but I never could get excited enough about the position to enter a green thumb. The stock has gyrated quite a bit since we took our initial position but we never took advantage of the cycles and I recently… More

NASDAQ:IOVA VS S&P 500 (SPY)

NASDAQ:IOVA Summary

Recent Community Commentary

Read the most recent pitches from players about IOVA.

Recs

0
Member Avatar TMFBlacknGold (94.01) Submitted: 10/3/2019 11:11:56 AM : Outperform Start Price: $19.99 NASDAQ:IOVA Score: -0.05

From 08/27/2019:

"Iovance Biotherapeutics is well-positioned to raise the standard in treating advanced cervical cancer and advanced melanoma. The two lead indications for LN-145 and LN-144 are expected to generate over $1 billion in combined peak annual sales. That doesn't take into account earlier-stage research in additional indications such as ovarian and bladder cancers, nor does it appear to factor into the company's current $2.4 billion valuation. If the results hold up and the TIL therapies can stave off potential competition from the fast-paced field of immunotherapy and cellular medicines, then investors buying the dip today should be rewarded for their long-term mindset."

https://www.fool.com/investing/2019/08/27/iovance-biotherapeutics-buy-the-dip.aspx

Recs

0
Member Avatar FVelociraptor (99.92) Submitted: 9/28/2019 8:32:34 PM : Underperform Start Price: $18.27 NASDAQ:IOVA Score: -13.32

https://velociraptor.cc

Recs

0
Member Avatar SmartAce (99.97) Submitted: 5/15/2017 12:03:05 PM : Underperform Start Price: $6.13 NASDAQ:IOVA Score: -223.72

Sometimes when I'm sitting in a swivel chair, I'll turn around quickly and smile and pretend I'm in the opening credits of a sitcom.

Leaderboard

Find the members with the highest scoring picks in IOVA.

Score Leader

mrmrmrj

mrmrmrj (53.58) Score: +253.54

The Score Leader is the player with the highest score across all their picks in IOVA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
mrmrmrj 53.58 8/31/2017 Outperform 5Y $5.70 +279.47% +25.94% +253.54 0 Comment
TruffelPig < 20 3/1/2016 Outperform 5Y $5.54 +290.43% +59.47% +230.96 0 Comment
Speedster 95.56 9/5/2017 Outperform 5Y $6.20 +248.87% +25.77% +223.10 0 Comment
DorminABC 99.88 7/25/2011 Underperform NS $154.00 -85.95% +133.29% +219.25 0 Comment
charityfund 51.55 6/5/2017 Outperform 3M $6.25 +246.08% +27.47% +218.61 0 Comment
Bosscats 38.00 12/9/2016 Outperform 5Y $6.90 +213.48% +37.78% +175.70 0 Comment
manirg < 20 10/16/2015 Outperform 5Y $6.65 +225.26% +53.31% +171.95 0 Comment
portefeuille 98.35 5/23/2014 Outperform 5Y $6.50 +232.77% +63.51% +169.26 0 Comment
wmtworker 79.36 1/4/2018 Outperform 5Y $8.30 +160.60% +14.67% +145.93 0 Comment
ababrmon 73.45 8/3/2015 Outperform 1Y $7.96 +171.82% +47.87% +123.94 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for IOVA.